You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inclisiran

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)

Not yet recruiting
  • Primary Hypercholesterolemia or Mixed Dyslipidemia
  • Inclisiran
  • Matching Placebo for Inclisiran
  • (no location specified)
May 24, 2023

Hypercholesterolemia Trial (Inclisiran, Ezetimibe, Matching Placebo for Inclisiran)

Not yet recruiting
  • Hypercholesterolemia
  • Inclisiran
  • +3 more
  • (no location specified)
Feb 28, 2023

Heterozygous or Homozygous Familial Hypercholesterolemia Trial (Inclisiran)

Not yet recruiting
  • Heterozygous or Homozygous Familial Hypercholesterolemia
  • Inclisiran
  • (no location specified)
Dec 27, 2022

Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)

Enrolling by invitation
  • Hypercholesterolemia
  • Atherosclerotic Ischemic Disease
  • lerodalcibep
  • Inclisiran
  • Nantes, Cedex 01, France
  • +6 more
Nov 3, 2022

Atherosclerotic Cardiovascular Disease Trial in Boston, Oxford (Inclisiran, Placebo)

Recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran
  • Placebo
  • Boston, Massachusetts
  • +1 more
Mar 1, 2022

Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Inclisiran
  • Behavioural Support
  • Sale, Cheshire, United Kingdom
  • +16 more
Jan 20, 2023

Qualitative Features of Atherosclerotic Plaques

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran
  • Riga, Latvia
    Pauls Stradins Clinical University Hospital
Dec 5, 2022

Atherosclerotic Cardiovascular Disease Trial in United States (Inclisiran)

Recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran
  • Little Rock, Arkansas
  • +43 more
Jan 20, 2023

Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

Not yet recruiting
  • Hypercholesterolemia
  • +3 more
  • Inclisiran
  • +2 more
  • Cambridge, United Kingdom
    University of Cambridge
Jan 13, 2023

Familial Hypercholesterolemia - Heterozygous Trial in Worldwide (Inclisiran, Placebo)

Recruiting
  • Familial Hypercholesterolemia - Heterozygous
  • Inclisiran
  • Placebo
  • Tucson, Arizona
  • +76 more
Aug 8, 2022

Acute Coronary Syndrome Trial in United States (Inclisiran)

Recruiting
  • Acute Coronary Syndrome
  • Inclisiran
  • Huntsville, Alabama
  • +77 more
Jan 13, 2023

Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes Trial in Worldwide (Inclisiran, Evolocumab)

Completed
  • Atherosclerotic Cardiovascular Disease
  • +3 more
  • Jacksonville, Florida
  • +51 more
Feb 7, 2022

Heterozygous Familial Hypercholesterolemia, Elevated Cholesterol Trial in Worldwide (Inclisiran, Placebo)

Completed
Has Results
  • Heterozygous Familial Hypercholesterolemia
  • Elevated Cholesterol
  • Inclisiran
  • Placebo
  • Mission Viejo, California
  • +44 more
Oct 6, 2020

Renal Impairment Trial in Auckland, Christchurch (Inclisiran)

Completed
  • Renal Impairment
  • Inclisiran
  • Auckland, New Zealand
  • +1 more
Nov 8, 2018